CELLINK and Carcinotech partner to transform cancer drug development with 3D bioprinting

Carcinotech and 3D bioprinting firm CELLINK have announced a partnership to accelerate cancer drug development with 3D bioprinted tumor models.  The partnership will focus on the development and commercialization of cutting-edge protocols for the biofabrication of 3D bioprinted tumor models using cancer cell lines. These models are designed to significantly improve accuracy and speed up […]